Montelukast in 2- to 5-year-old children with asthma.

D Skoner

Journal: Pediatric pulmonology. Supplement 2001;21():46-8

PMID: 11475172

Abstract

Pediatric dose selection for montelukast in 2-5-year-old children was based on a pharmacokinetic approach that was also used in previously selecting a once-daily 5-mg chewable tablet for asthmatic children 6-14 years of age. A 4-mg chewable tablet administered once daily was determined to be the correct dose and was subsequently found to be safe and effective in asthmatic children 2-5 years of age.

Address: Department of Allergy and Immunology, Children's Hospital of Pittsburgh, 3705 Fifth Ave., 4B 320, Pittsburgh, PA 15213, USA. [email protected]

DOI: 10.1002/ppul.2006

Link outs

Free resources

Medical:

https://medlineplus.gov/asthmainchildren.html
https://medlineplus.gov/asthma.html

MeSH Terms: Acetates, Administration, Oral, Asthma, Child, Preschool, Cyclopropanes, Female, Humans, Leukotriene Antagonists, Male, Quinolines, Sulfides